-
1
-
-
1542348477
-
Cancer statistics
-
Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, Feuer EJ, Thun MJ. Cancer statistics. CA Cancer J Clin 2004; 54:8-29.
-
(2004)
CA Cancer J Clin
, vol.54
, pp. 8-29
-
-
Jemal, A.1
Tiwari, R.C.2
Murray, T.3
Ghafoor, A.4
Samuels, A.5
Ward, E.6
Feuer, E.J.7
Thun, M.J.8
-
2
-
-
1242291844
-
Effects of a high-selenium yeast supplement on celecoxib plasma levels: A randomized phase II trial
-
Frank DH, Roe DJ, Chow HH, Guillen JM, Choquette K, Gracie D, Francis J, Fish A, Alberts DS. Effects of a high-selenium yeast supplement on celecoxib plasma levels: A randomized phase II trial. Cancer Epidemiol Biomarkers Prev 2004; 13:299-303.
-
(2004)
Cancer Epidemiol Biomarkers Prev
, vol.13
, pp. 299-303
-
-
Frank, D.H.1
Roe, D.J.2
Chow, H.H.3
Guillen, J.M.4
Choquette, K.5
Gracie, D.6
Francis, J.7
Fish, A.8
Alberts, D.S.9
-
3
-
-
0025064250
-
Activity of methylated forms of selenium in cancer prevention
-
Ip C, Ganther HE. Activity of methylated forms of selenium in cancer prevention. Cancer Res 1990; 50:1206-11.
-
(1990)
Cancer Res
, vol.50
, pp. 1206-1211
-
-
Ip, C.1
Ganther, H.E.2
-
4
-
-
0034214376
-
In vitro and in vivo studies of methylseleninic acid: Evidence that a monomethylated selenium metabolite is critical for cancer chemoprevention
-
Ip C, Thompson HJ, Zhu Z, Ganther HE. In vitro and in vivo studies of methylseleninic acid: Evidence that a monomethylated selenium metabolite is critical for cancer chemoprevention. Cancer Res 2000; 60:2882-6.
-
(2000)
Cancer Res
, vol.60
, pp. 2882-2886
-
-
Ip, C.1
Thompson, H.J.2
Zhu, Z.3
Ganther, H.E.4
-
5
-
-
0037224465
-
Delineation of the molecular basis for selenium-induced growth arrest in human prostate cancer cells by oligonucleotide array
-
Dong Y, Zhang H, Hawthorn L, Ganther HE, Ip C. Delineation of the molecular basis for selenium-induced growth arrest in human prostate cancer cells by oligonucleotide array. Cancer Res 2003; 63:52-9.
-
(2003)
Cancer Res
, vol.63
, pp. 52-59
-
-
Dong, Y.1
Zhang, H.2
Hawthorn, L.3
Ganther, H.E.4
Ip, C.5
-
6
-
-
0142219868
-
Synergy between selenium and vitamin e in apoptosis induction is associated with activation of distinctive initiator caspases in human prostate cancer cells
-
Zu K, Ip C. Synergy between selenium and vitamin E in apoptosis induction is associated with activation of distinctive initiator caspases in human prostate cancer cells. Cancer Res 2003; 63:6988-95.
-
(2003)
Cancer Res
, vol.63
, pp. 6988-6995
-
-
Zu, K.1
Ip, C.2
-
7
-
-
0141922731
-
SELECT: The selenium and vitamin e cancer prevention trial
-
Klein EA, Thompson IM, Lippman SM, Goodman PJ, Albanes D, Taylor PR, Coltman C. SELECT: The selenium and vitamin E cancer prevention trial. Urol Oncol 2003; 21:59-65.
-
(2003)
Urol Oncol
, vol.21
, pp. 59-65
-
-
Klein, E.A.1
Thompson, I.M.2
Lippman, S.M.3
Goodman, P.J.4
Albanes, D.5
Taylor, P.R.6
Coltman, C.7
-
8
-
-
0021837469
-
The epidemiology of selenium and cancer
-
Clark LC. The epidemiology of selenium and cancer. Fed Proc 1985; 44:2584-9.
-
(1985)
Fed Proc
, vol.44
, pp. 2584-2589
-
-
Clark, L.C.1
-
9
-
-
1642625262
-
Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial
-
Nutritional Prevention of Cancer Study Group
-
Clark LC, Combs Jr GF, Turnbull BW, Slate EH, Chalker DK, Chow J, Davis LS, Glover RA, Graham GF, Gross EG, Krongrad A, Lesher Jr JL, Park HK, Sanders Jr BB, Smith CL, Taylor JR. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA 1996; 276:1957-63.
-
(1996)
JAMA
, vol.276
, pp. 1957-1963
-
-
Clark, L.C.1
Combs Jr., G.F.2
Turnbull, B.W.3
Slate, E.H.4
Chalker, D.K.5
Chow, J.6
Davis, L.S.7
Glover, R.A.8
Graham, G.F.9
Gross, E.G.10
Krongrad, A.11
Lesher Jr., J.L.12
Park, H.K.13
Sanders Jr., B.B.14
Smith, C.L.15
Taylor, J.R.16
-
10
-
-
0036678773
-
Serum selenium and risk of large size colorectal adenomas in a geographical area with a low selenium status
-
Fernandez-Banares F, Cabre E, Esteve M, Mingorance MD, Abad-Lacruz A, Lachica M, Gil A, Gassull MA. Serum selenium and risk of large size colorectal adenomas in a geographical area with a low selenium status. Am J Gastroenterol 2002; 97:2103-8.
-
(2002)
Am J Gastroenterol
, vol.97
, pp. 2103-2108
-
-
Fernandez-Banares, F.1
Cabre, E.2
Esteve, M.3
Mingorance, M.D.4
Abad-Lacruz, A.5
Lachica, M.6
Gil, A.7
Gassull, M.A.8
-
11
-
-
0033792475
-
A case-control study of toenail selenium and cancer of the breast, colon, and prostate
-
Ghadirian P, Maisonneuve P, Perret C, Kennedy G, Boyle P, Krewski D, Lacroix A. A case-control study of toenail selenium and cancer of the breast, colon, and prostate. Cancer Detect Prev 2000; 24:305-13.
-
(2000)
Cancer Detect Prev
, vol.24
, pp. 305-313
-
-
Ghadirian, P.1
Maisonneuve, P.2
Perret, C.3
Kennedy, G.4
Boyle, P.5
Krewski, D.6
Lacroix, A.7
-
12
-
-
0345310068
-
Chemopreventive agents: Selenium
-
Combs Jr GF, Gray WP. Chemopreventive agents: Selenium. Pharmacol Ther 1998; 79:179-92.
-
(1998)
Pharmacol Ther
, vol.79
, pp. 179-192
-
-
Combs Jr., G.F.1
Gray, W.P.2
-
13
-
-
0026969562
-
Selenium in the treatment of heavy metal poisoning and chemical carcinogenesis
-
Whanger PD. Selenium in the treatment of heavy metal poisoning and chemical carcinogenesis. J Trace Elem Electrolytes Health Dis 1992; 6:209-21.
-
(1992)
J Trace Elem Electrolytes Health Dis
, vol.6
, pp. 209-221
-
-
Whanger, P.D.1
-
14
-
-
0033667716
-
Tumorigenesis, metabolism, speciation, bioavailability, and tissue deposition of selenium in selenium-enriched ramps (Allium tricoccum)
-
Whanger PD, Ip C, Polan CE, Uden PC, Welbaum G. Tumorigenesis, metabolism, speciation, bioavailability, and tissue deposition of selenium in selenium-enriched ramps (Allium tricoccum). J Agric Food Chem 2000; 48:5723-30.
-
(2000)
J Agric Food Chem
, vol.48
, pp. 5723-5730
-
-
Whanger, P.D.1
Ip, C.2
Polan, C.E.3
Uden, P.C.4
Welbaum, G.5
-
15
-
-
0346707259
-
Selenium and its relationship to cancer: An update dagger
-
Whanger PD. Selenium and its relationship to cancer: An update dagger. Br J Nutr 2004; 91:11-28.
-
(2004)
Br J Nutr
, vol.91
, pp. 11-28
-
-
Whanger, P.D.1
-
16
-
-
0030055822
-
Selenium-mediated inhibition of transcription factor NF-kappa B and HIV-1 LTR promoter activity
-
Makropoulos V, Bruning T, Schulze-Osthoff K. Selenium-mediated inhibition of transcription factor NF-kappa B and HIV-1 LTR promoter activity. Arch Toxicol 1996; 70:277-83.
-
(1996)
Arch Toxicol
, vol.70
, pp. 277-283
-
-
Makropoulos, V.1
Bruning, T.2
Schulze-Osthoff, K.3
-
17
-
-
0030950749
-
Differential induction of growth arrest inducible genes by selenium compounds
-
Kaeck M, Lu J, Strange R, Ip C, Ganther HE, Thompson HJ. Differential induction of growth arrest inducible genes by selenium compounds. Biochem Pharmacol 1997; 53:921-6.
-
(1997)
Biochem Pharmacol
, vol.53
, pp. 921-926
-
-
Kaeck, M.1
Lu, J.2
Strange, R.3
Ip, C.4
Ganther, H.E.5
Thompson, H.J.6
-
18
-
-
0031869119
-
Inhibition of DNA cytosine methyltransferase by chemopreventive selenium compounds, determined by an improved assay for DNA cytosine methyltransferase and DNA cytosine methylation
-
Fiala ES, Staretz ME, Pandya GA, El Bayoumy K, Hamilton SR. Inhibition of DNA cytosine methyltransferase by chemopreventive selenium compounds, determined by an improved assay for DNA cytosine methyltransferase and DNA cytosine methylation. Carcinogenesis 1998; 19:597-604.
-
(1998)
Carcinogenesis
, vol.19
, pp. 597-604
-
-
Fiala, E.S.1
Staretz, M.E.2
Pandya, G.A.3
El Bayoumy, K.4
Hamilton, S.R.5
-
19
-
-
0035001508
-
Methylselenocysteine modulates proliferation and apoptosis biomarkers in premalignant lesions of the rat mammary gland
-
Ip C, Dong Y. Methylselenocysteine modulates proliferation and apoptosis biomarkers in premalignant lesions of the rat mammary gland. Anticancer Res 2001; 21:803-7.
-
(2001)
Anticancer Res
, vol.21
, pp. 803-807
-
-
Ip, C.1
Dong, Y.2
-
20
-
-
0035679690
-
Molecular mechanisms of cancer prevention by selenium compounds
-
Fleming J, Ghose A, Harrison PR. Molecular mechanisms of cancer prevention by selenium compounds. Nutr Cancer 2001; 40:42-9.
-
(2001)
Nutr Cancer
, vol.40
, pp. 42-49
-
-
Fleming, J.1
Ghose, A.2
Harrison, P.R.3
-
21
-
-
0041546160
-
Selenomethionine inhibits growth and suppresses cyclooxygenase-2 (COX-2) protein expression in human colon cancer cell lines
-
Baines A, Taylor-Parker M, Goulet AC, Renaud C, Gerner EW, Nelson MA. Selenomethionine inhibits growth and suppresses cyclooxygenase-2 (COX-2) protein expression in human colon cancer cell lines. Cancer Biol Ther 2002; 1:370-4.
-
(2002)
Cancer Biol Ther
, vol.1
, pp. 370-374
-
-
Baines, A.1
Taylor-Parker, M.2
Goulet, A.C.3
Renaud, C.4
Gerner, E.W.5
Nelson, M.A.6
-
22
-
-
1242295294
-
Rapid induction of apoptosis in prostate cancer cells by selenium: Reversal by metabolites of arachidonate 5-lipoxygenase
-
Ghosh J. Rapid induction of apoptosis in prostate cancer cells by selenium: Reversal by metabolites of arachidonate 5-lipoxygenase. Biochem Biophys Res Commun 2004; 315:624-35.
-
(2004)
Biochem Biophys Res Commun
, vol.315
, pp. 624-635
-
-
Ghosh, J.1
-
23
-
-
0037195158
-
Selenomethionine regulation of p53 by a ref1-dependent redox mechanism
-
USA
-
Seo YR, Kelley MR, Smith ML. Selenomethionine regulation of p53 by a ref1-dependent redox mechanism. Proc Natl Acad Sci USA 2002; 99:14548-53.
-
(2002)
Proc Natl Acad Sci
, vol.99
, pp. 14548-14553
-
-
Seo, Y.R.1
Kelley, M.R.2
Smith, M.L.3
-
24
-
-
0032848137
-
Selenium metabolism, selenoproteins and mechanisms of cancer prevention: Complexities with thioredoxin reductase
-
Ganther HE. Selenium metabolism, selenoproteins and mechanisms of cancer prevention: Complexities with thioredoxin reductase. Carcinogenesis 1999; 20:1657-66.
-
(1999)
Carcinogenesis
, vol.20
, pp. 1657-1666
-
-
Ganther, H.E.1
-
25
-
-
0030598160
-
Organic and inorganic selenium compounds inhibit mouse mammary cell growth in vitro by different cellular pathways
-
Sinha R, Said TK, Medina D. Organic and inorganic selenium compounds inhibit mouse mammary cell growth in vitro by different cellular pathways. Cancer Lett 1996; 107:277-84.
-
(1996)
Cancer Lett
, vol.107
, pp. 277-284
-
-
Sinha, R.1
Said, T.K.2
Medina, D.3
-
26
-
-
0028784167
-
Microsatellite instability, mismatch repair deficiency, and genetic defects in human cancer cell lines
-
Boyer JC, Umar A, Risinger JI, Lipford JR, Kane M, Yin S, Barrett JC, Kolodner RD, Kunkel TA. Microsatellite instability, mismatch repair deficiency, and genetic defects in human cancer cell lines. Cancer Res 1995; 55:6063-70.
-
(1995)
Cancer Res
, vol.55
, pp. 6063-6070
-
-
Boyer, J.C.1
Umar, A.2
Risinger, J.I.3
Lipford, J.R.4
Kane, M.5
Yin, S.6
Barrett, J.C.7
Kolodner, R.D.8
Kunkel, T.A.9
-
27
-
-
0033135049
-
Methylation of CpG in a small region of the hMLH1 promoter invariably correlates with the absence of gene expression
-
Deng G, Chen A, Hong J, Chae HS, Kim YS. Methylation of CpG in a small region of the hMLH1 promoter invariably correlates with the absence of gene expression. Cancer Res 1999; 59:2029-33.
-
(1999)
Cancer Res
, vol.59
, pp. 2029-2033
-
-
Deng, G.1
Chen, A.2
Hong, J.3
Chae, H.S.4
Kim, Y.S.5
-
28
-
-
0030587392
-
p21 (WAF1/CIP1) expression is induced in newly nondividing cells in diverse epithelia and during differentiation of the Caco-2 intestinal cell line
-
Gartel AL, Serfas MS, Gartel M, Goufman E, Wu GS, el Deiry WS, Tyner AL. p21 (WAF1/CIP1) expression is induced in newly nondividing cells in diverse epithelia and during differentiation of the Caco-2 intestinal cell line. Exp Cell Res 1996; 227:171-81.
-
(1996)
Exp Cell Res
, vol.227
, pp. 171-181
-
-
Gartel, A.L.1
Serfas, M.S.2
Gartel, M.3
Goufman, E.4
Wu, G.S.5
El Deiry, W.S.6
Tyner, A.L.7
-
29
-
-
0032513272
-
Inhibitory effect of selenomethionine on the growth of three selected human tumor cell lines
-
Redman C, Scott JA, Baines AT, Basye JL, Clark LC, Calley C, Roe D, Payne CM, Nelson MA. Inhibitory effect of selenomethionine on the growth of three selected human tumor cell lines. Cancer Lett 1998; 125:103-10.
-
(1998)
Cancer Lett
, vol.125
, pp. 103-110
-
-
Redman, C.1
Scott, J.A.2
Baines, A.T.3
Basye, J.L.4
Clark, L.C.5
Calley, C.6
Roe, D.7
Payne, C.M.8
Nelson, M.A.9
-
30
-
-
0035125529
-
Inhibition of mitotic cyclin B and cdc2 kinase activity by selenomethionine in synchronized colon cancer cells
-
Chigbrow M, Nelson M. Inhibition of mitotic cyclin B and cdc2 kinase activity by selenomethionine in synchronized colon cancer cells. Anticancer Drugs 2001; 12:43-50.
-
(2001)
Anticancer Drugs
, vol.12
, pp. 43-50
-
-
Chigbrow, M.1
Nelson, M.2
-
31
-
-
8444242459
-
Selenomethionine stimulates MAPK (ERK) phosphorylation, protein oxidation, and DNA synthesis in gastric cancer cells
-
Verma A, Atten MJ, Attar BM, Holian O. Selenomethionine stimulates MAPK (ERK) phosphorylation, protein oxidation, and DNA synthesis in gastric cancer cells. Nutr Cancer 2004; 49:184-90.
-
(2004)
Nutr Cancer
, vol.49
, pp. 184-190
-
-
Verma, A.1
Atten, M.J.2
Attar, B.M.3
Holian, O.4
-
33
-
-
0028985995
-
The development of an eluted stain bioassay (ESTA) for human growth hormone
-
Ealey PA, Yateman ME, Sandhu R, Dattani MT, Hassan MK, Holt SJ, Marshall NJ. The development of an eluted stain bioassay (ESTA) for human growth hormone. Growth Regul 1995; 5:36-44.
-
(1995)
Growth Regul
, vol.5
, pp. 36-44
-
-
Ealey, P.A.1
Yateman, M.E.2
Sandhu, R.3
Dattani, M.T.4
Hassan, M.K.5
Holt, S.J.6
Marshall, N.J.7
-
34
-
-
0025026002
-
A review of techniques and results obtained in one laboratory by an integrated system of methods designed for routine clinical flow cytometric DNA analysis
-
Vindelov LL, Christensen IJ. A review of techniques and results obtained in one laboratory by an integrated system of methods designed for routine clinical flow cytometric DNA analysis. Cytometry 1990; 11:753-70.
-
(1990)
Cytometry
, vol.11
, pp. 753-770
-
-
Vindelov, L.L.1
Christensen, I.J.2
-
35
-
-
0037239781
-
A novel mechanism for aspirin-mediated growth inhibition of human colon cancer cells
-
Goel A, Chang DK, Ricciardiello L, Gasche C, Boland CR. A novel mechanism for aspirin-mediated growth inhibition of human colon cancer cells. Clin Cancer Res 2003; 9:383-90.
-
(2003)
Clin Cancer Res
, vol.9
, pp. 383-390
-
-
Goel, A.1
Chang, D.K.2
Ricciardiello, L.3
Gasche, C.4
Boland, C.R.5
-
36
-
-
0029838771
-
Expression of human MutS homolog 2 (hMSH2) protein in resting and proliferating cells
-
Marra G, Chang CL, Laghi LA, Chauhan DP, Young D, Boland CR. Expression of human MutS homolog 2 (hMSH2) protein in resting and proliferating cells. Oncogene 1996; 13:2189-96.
-
(1996)
Oncogene
, vol.13
, pp. 2189-2196
-
-
Marra, G.1
Chang, C.L.2
Laghi, L.A.3
Chauhan, D.P.4
Young, D.5
Boland, C.R.6
-
37
-
-
0033092234
-
Early detection and prevention of colorectal cancer
-
Dashwood RH. Early detection and prevention of colorectal cancer (review). Oncol Rep 1999; 6:277-81.
-
(1999)
Oncol Rep
, vol.6
, pp. 277-281
-
-
Dashwood, R.H.1
-
38
-
-
0030826797
-
The role of apoptosis in the modulation of colon carcinogenesis by dietary fat and by the organoselenium compound 1,4-phenylenebis(methylene) selenocyanate
-
Samaha HS, Hamid R, El Bayoumy K, Rao CV, Reddy BS. The role of apoptosis in the modulation of colon carcinogenesis by dietary fat and by the organoselenium compound 1,4-phenylenebis(methylene)selenocyanate. Cancer Epidemiol Biomarkers Prev 1997; 6:699-704.
-
(1997)
Cancer Epidemiol Biomarkers Prev
, vol.6
, pp. 699-704
-
-
Samaha, H.S.1
Hamid, R.2
El Bayoumy, K.3
Rao, C.V.4
Reddy, B.S.5
-
40
-
-
13444293451
-
Selenomethionine induces sustained ERK phosphorylation leading to cell-cycle arrest in human colon cancer cells
-
Goulet AC, Chigbrow M, Frisk P, Nelson MA. Selenomethionine induces sustained ERK phosphorylation leading to cell-cycle arrest in human colon cancer cells. Carcinogenesis 2005; 26:109-17.
-
(2005)
Carcinogenesis
, vol.26
, pp. 109-117
-
-
Goulet, A.C.1
Chigbrow, M.2
Frisk, P.3
Nelson, M.A.4
-
42
-
-
0033230581
-
The cellular response to p53: The decision between life and death
-
Sionov RV, Haupt Y. The cellular response to p53: The decision between life and death. Oncogene 1999; 18:6145-57.
-
(1999)
Oncogene
, vol.18
, pp. 6145-6157
-
-
Sionov, R.V.1
Haupt, Y.2
-
43
-
-
0031310665
-
2/M progression
-
2/M progression. Mol Cell 1997; 1:3-11.
-
(1997)
Mol Cell
, vol.1
, pp. 3-11
-
-
Hermeking, H.1
Lengauer, C.2
Polyak, K.3
He, T.C.4
Zhang, L.5
Thiagalingam, S.6
Kinzler, K.W.7
Vogelstein, B.8
-
45
-
-
5444271774
-
A new effector pathway links ATM kinase with the DNA damage response
-
Demonacos C, Krstic-Demonacos M, Smith L, Xu D, O'Connor DP, Jansson M, La Thangue NB. A new effector pathway links ATM kinase with the DNA damage response. Nat Cell Biol 2004; 6:968-76.
-
(2004)
Nat Cell Biol
, vol.6
, pp. 968-976
-
-
Demonacos, C.1
Krstic-Demonacos, M.2
Smith, L.3
Xu, D.4
O'Connor, D.P.5
Jansson, M.6
La Thangue, N.B.7
|